Catalyst Pharmaceuticals, Inc.
CEO
2024-01-01–present
CEO
Catalyst Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Richard Daly is recorded as CEO at Catalyst Pharmaceuticals, Inc.. Richard Daly has spoken on 8 earnings calls across 1 company, most recently for Catalyst Pharmaceuticals, Inc. on September 30, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Catalyst Pharmaceuticals, Inc.
CEO
Proxy statement
Catalyst Pharmaceuticals, Inc.
Board Member
Proxy statement
2024-01-01–2026-07-08
Recorded roles and call appearances connecting this person to public companies.
Catalyst Pharmaceuticals, Inc.
CEO
2024-01-01–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
Catalyst Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q2 FY2025 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q1 FY2025 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q4 FY2024 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q3 FY2024 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q2 FY2024 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q1 FY2024 Earnings Call
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Q4 FY2023 Earnings Call
Catalyst Pharmaceuticals, Inc.